Day

Atul Varadhachary writes an opinion piece in the Houston Chronicle explaining why India must enact policy changes that reward investment in biopharmaceutical innovation: India must expedite the implementation of formal policy changes, especially for regulatory and intellectual property protection reforms, that reward investment in biopharmaceu...